These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4123602)

  • 21. Hepatitis B vaccines in patients with chronic renal failure before dialysis.
    Seaworth B; Drucker J; Starling J; Drucker R; Stevens C; Hamilton J
    J Infect Dis; 1988 Feb; 157(2):332-7. PubMed ID: 2961818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Incidence of HBeAg in hemodialysis patients: preliminary data (author's transl)].
    Toti M; Alegente G; Almi P; Rubino M; Marini M; Facchini C
    Ann Sclavo; 1980; 22(3):455-8. PubMed ID: 7247498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodialysis patients waiting for a kidney transplant: immunologic investigation.
    Casciani CU; De Simone C; Adorno D; Meli D; Cicogna VA; Piazza A; Masala C
    Transplant Proc; 1979 Mar; 11(1):115-8. PubMed ID: 452094
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients.
    Desmyter J; Bradburne AF; Vermylen C; Daneels R; Boelaert J
    Lancet; 1975 Aug; 2(7931):376-7. PubMed ID: 51188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-HBs prevalence in hemodialysed patients with acute renal failure.
    Babes VT; Tatu A; Filipescu Z
    Virologie; 1979; 30(3):229-30. PubMed ID: 538883
    [No Abstract]   [Full Text] [Related]  

  • 26. [Presence of Australia antigen and homologous antibodies in patients with acute renal failure treated by hemodialysis].
    Sandu L
    Stud Cercet Virusol; 1973; 24(5):375-9. PubMed ID: 4747457
    [No Abstract]   [Full Text] [Related]  

  • 27. [THE PRESENT PLACE OF PERITONEAL DIALYSIS AMONG METHODS OF EXTRARENAL PURIFICATION. (APROPOS OF 100 PATIENTS WITH ACUTE AND CHRONIC RENAL INSUFFICIENCY)].
    DELAVAL E
    Anesth Analg (Paris); 1964; 21():405-12. PubMed ID: 14180372
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rapid vaccination protocol against hepatitis B in patients with chronic kidney failure].
    Teruel JL; Fernández Lucas M; Mateos ML; Ortuño J
    Nefrologia; 2005; 25(3):338-9. PubMed ID: 16053018
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the response to the recombinant vaccine against hepatitis B virus in dialyzed and nondialyzed children with CRF using different doses and routes of administration.
    Vazquez G; Mendoza-Guevara L; Alvarez T; Aguilar A; Morales A; Rodriguez F; Solorzano F; Garcia-Lopez E; Muñoz O
    Adv Perit Dial; 1997; 13():291-6. PubMed ID: 9360702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the electroimmunoprecipitation method used for the detection of Australia antigen and anti-Australia antibodies].
    Kacperska E; Bragiel I; Seyfriedowa H
    Acta Haematol Pol; 1972; 3(2):125-31. PubMed ID: 4655611
    [No Abstract]   [Full Text] [Related]  

  • 31. Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin.
    Steketee RW; Ziarnik ME; Davis JP
    Am J Epidemiol; 1988 Apr; 127(4):772-82. PubMed ID: 2965510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of the specificity of HBe antigen in patients on a hemodialysis unit].
    Pillot J; Capel F; Bognel F
    Nouv Presse Med; 1980 Jan; 9(1):49. PubMed ID: 6153463
    [No Abstract]   [Full Text] [Related]  

  • 33. [Australia antigen (Au-SH) and its significance in the diagnosis and prevention of serum hepatitis. 3. Study on the incidence of anti Au-SH antibodies].
    Gáliková J; Pokorná G; Hrubisko M; Kubánová E
    Bratisl Lek Listy; 1973; 59(1):39-44. PubMed ID: 4691527
    [No Abstract]   [Full Text] [Related]  

  • 34. [Serum complement in patients with chronic renal insufficiency undergoing periodic hemodialysis].
    De Simone C; Perricone R; Taccone Gallucci M; Rovina R; Fontana L; Casciani CU
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):757-60. PubMed ID: 552824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Australia antigen and antibodies in serums of patients with acute viral hepatitis hospitalized in Slavonski Brod].
    Jelić O; Cubelić P; Fiser-Herman M
    Acta Med Iugosl; 1973; 27(2):119-28. PubMed ID: 4709920
    [No Abstract]   [Full Text] [Related]  

  • 36. Immune-complexes and Australia antigen in cryoglobulinemic sera.
    Realdi G; Alberti A; Rigoli A; Tremolada F
    Z Immunitatsforsch Exp Klin Immunol; 1974 Jun; 147(2):114-26. PubMed ID: 4283002
    [No Abstract]   [Full Text] [Related]  

  • 37. [Method for the serological determination of hepatitis B antigen e].
    Kliuchareva AA; Voĭtenok NN
    Lab Delo; 1979; (10):604-6. PubMed ID: 94129
    [No Abstract]   [Full Text] [Related]  

  • 38. Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis.
    Ankersmit HJ; Deicher R; Moser B; Teufel I; Roth G; Gerlitz S; Itescu S; Wolner E; Boltz-Nitulescu G; Kovarik J
    Clin Exp Immunol; 2001 Jul; 125(1):142-8. PubMed ID: 11472437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Australia antigen and hepatitis.
    Blumberg BS; Sutnick AI; London WT; Millman I
    N Engl J Med; 1970 Aug; 283(7):349-54. PubMed ID: 4246769
    [No Abstract]   [Full Text] [Related]  

  • 40. Vaccination against hepatitis B in patients with renal insufficiency.
    Bommer J; Grussendorf M; Jilg W; Deinhardt F; Koch HG; Darai G; Bommer G; Rambausek M; Ritz E
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():300-5. PubMed ID: 3991515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.